The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer

This publication has 25 references indexed in Scilit:

• American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
  Journal of Clinical Oncology, 2004
• Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
  British Journal of Cancer, 2004
• Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
  Annals of Oncology, 2003
• Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy
  The Lancet Oncology, 2003
• Systemic inflammatory response predicts survival following curative resection of colorectal cancer
  British Journal of Surgery, 2003
• Levels of some Acute-Phase Proteins in the Serum of Patients with Cancer during Radiotherapy
  Biological & Pharmaceutical Bulletin, 2003
• Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
  British Journal of Cancer, 2002
• Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation
  British Journal of Cancer, 2002
• Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer
  Annals of Surgical Oncology, 2000
• Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
  Nutrition and Cancer, 2000